A Study to Assess the Mass Balance Recovery (Absorption, Distribution, Metabolism and Excretion) of [14C]CCX168 in Healthy Participants

NCT06004960 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis

Interventions

DRUG: [14C]CCX168

Sponsor

Amgen